Optical fluorescence and Raman biopsy of squamous cell carcinoma from the head and neck

被引:3
|
作者
Yang, YL [1 ]
Liu, CH [1 ]
Savage, HE [1 ]
Schantz, S [1 ]
Alfano, RR [1 ]
机构
[1] CUNY City Coll, Inst Ultrafast Spect & Lasers, New York State Ctr Adv Technol Ultrafast Photon M, New York, NY 10031 USA
来源
关键词
biopsy; excitation fluorescence spectrum; Raman spectroscopy; squamous cell carcinoma;
D O I
10.1117/12.305364
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Fluorescence, excitation, diffuse reflectance and FT-IR Raman spectral scans of squamous cell carcinoma of the head and neck have been studed. Eleven specimens of squamous cell carcinoma in larynx, lymph node, throat, grand, soft palate and epiglotts and nine corresponding normal specimens was tested. The excitation spectral differences between squamous cell carcinoma and normal were investigated in the protein spectral range 260 nm to 300 nm. The ratios intensity at various excitation wavelengths were used as criterion to separate carcinoma and normal tissues. The t-test of these parameter have been made. The P values of all these three parameters sue Less than 0.005. The statistical results of sensitivity and specificity of using these three parameters compared to pathological results are about 90%. The Raman spectroscopy was measured. Characteristic vibrational modes were used to separate out carcinoma and correlated with excitation spectroscopy data.
引用
收藏
页码:68 / 71
页数:4
相关论文
共 50 条
  • [21] Liquid BIOpsy for MiNimal RESidual DiSease Detection in Head and Neck Squamous Cell Carcinoma (LIONESS)—a personalised circulating tumour DNA analysis in head and neck squamous cell carcinoma
    Susanne Flach
    Karen Howarth
    Sophie Hackinger
    Christodoulos Pipinikas
    Pete Ellis
    Kirsten McLay
    Giovanni Marsico
    Tim Forshew
    Christoph Walz
    Christoph A. Reichel
    Olivier Gires
    Martin Canis
    Philipp Baumeister
    British Journal of Cancer, 2022, 126 : 1186 - 1195
  • [22] Liquid BIOpsy for MiNimal RESidual DiSease Detection in Head and Neck Squamous Cell Carcinoma (LIONESS)-a personalised circulating tumour DNA analysis in head and neck squamous cell carcinoma
    Flach, Susanne
    Howarth, Karen
    Hackinger, Sophie
    Pipinikas, Christodoulos
    Ellis, Pete
    McLay, Kirsten
    Marsico, Giovanni
    Forshew, Tim
    Walz, Christoph
    Reichel, Christoph A.
    Gires, Olivier
    Canis, Martin
    Baumeister, Philipp
    BRITISH JOURNAL OF CANCER, 2022, 126 (08) : 1186 - 1195
  • [23] Circulating tumor DNA as a biomarker and liquid biopsy in head and neck squamous cell carcinoma
    Payne, Karl
    Spruce, Rachel
    Beggs, Andrew
    Sharma, Neil
    Kong, Anthony
    Martin, Timothy
    Parmar, Satyesh
    Praveen, Prav
    Nankivell, Paul
    Mehanna, Hisham
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2018, 40 (07): : 1598 - 1604
  • [24] Determining the clinical place of sentinel node biopsy in head and neck squamous cell carcinoma
    Thompson, R
    ORAL ONCOLOGY, 2005, 1 (01) : 54 - 54
  • [25] Rationale for sentinel node biopsy to stage NO head and neck squamous-cell carcinoma
    Ross, G
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2004, 19 (03) : 273 - 284
  • [26] Biomarkers of squamous cell carcinoma of the head and neck
    Kim, J
    Shin, DM
    HISTOLOGY AND HISTOPATHOLOGY, 1997, 12 (01) : 205 - 218
  • [27] Immunotherapy for Head and Neck Squamous Cell Carcinoma
    Moskovitz, Jessica
    Moy, Jennifer
    Ferris, Robert L.
    CURRENT ONCOLOGY REPORTS, 2018, 20 (02)
  • [29] Afatinib in squamous cell carcinoma of the head and neck
    Specenier, Pol
    Vermorken, Jan
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (09) : 1295 - 1301
  • [30] Docetaxel and squamous cell carcinoma of the head and neck
    Calais, G
    BULLETIN DU CANCER, 2004, 91 (02) : 167 - 171